AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21988218 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24 IU)
Number of subjects: 100
Study 21988218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 19356868 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise (ME) program
Number of subjects: 77
Study 19356868 — intervention group
Group type: COMPARATOR
Intervention: Resistance exercise (RE) program
Number of subjects: 77
Study 17233817 — intervention group
Group type: EXPERIMENTAL
Intervention: Melphalan plus dexamethasone (M‐Dex)
Number of subjects: 585
Study 17233817 — intervention group
Group type: COMPARATOR
Intervention: Melphalan plus prednisone (MP)
Number of subjects: 585
Study 17233817 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance dexamethasone
Number of subjects: 585
Study 17233817 — intervention group
Group type: COMPARATOR
Intervention: Observation (as maintenance therapy)
Number of subjects: 585
Study 14766686 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (5 microg.kg(‐1).hr(‐1) infusion, 25 microg boli, refractory period of five minutes)
Number of subjects: 77
Study 14766686 — intervention group
Group type: COMPARATOR
Intervention: Propofol (2 mg.kg(‐1).hr(‐1) infusion, 0.5 mg.kg(‐1) boli, refractory period of ten minutes)
Number of subjects: 77
Study 14766686 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 77
Study 14766686 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 77
Study 12370866 — intervention group
Group type: EXPERIMENTAL
Intervention: Ashworth Scale
Number of subjects: 9
Study 12370866 — intervention group
Group type: EXPERIMENTAL
Intervention: Disability Assessment Scale (DAS)
Number of subjects: 9
Study 9623023 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular ketoprofen
Number of subjects: 50
Study 9623023 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular morphine
Number of subjects: 50
Study 7814161 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrioventricular synchronous pacing
Number of subjects: 13
Study 7814161 — intervention group
Group type: COMPARATOR
Intervention: Ventricular pacing
Number of subjects: 13
Study 7814161 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological pacing
Number of subjects: 13
Study 2917114 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrronium 10 micrograms kg‐1
Number of subjects: 60
Study 2917114 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrronium 5 micrograms kg‐1
Number of subjects: 60
Study 2917114 — intervention group
Group type: COMPARATOR
Intervention: Glycopyrronium 5 micrograms kg‐1 and 10 micrograms kg‐1
Number of subjects: 60
Study 162675 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoxsuprine 10 mg, acetaminophen 250 mg, caffeine 30 mg
Number of subjects: 80
Study 31429790 — intervention group
Group type: EXPERIMENTAL
Intervention: Yi-Zhi-An-Shen granules (YZASG) administered three times a day for 16 weeks
Number of subjects: 80
Study 31429790 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered three times a day for 16 weeks
Number of subjects: 80
Study 31429790 — intervention group
Group type: EXPERIMENTAL
Intervention: Yi-Zhi-An-Shen granules (YZASG)
Number of subjects: 80
Study 31429790 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 24673165 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of oral zinc sulphate tablets for 14 days
Number of subjects: 134
Study 24673165 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 23840944 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with a social contact
Number of subjects: 92
Study 23840944 — intervention group
Group type: COMPARATOR
Intervention: Participants without a social contact
Number of subjects: 92
Study 21048508 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost
Number of subjects: 64
Study 21048508 — intervention group
Group type: COMPARATOR
Intervention: Latanoprost-timolol-fixed combination (LTFC)
Number of subjects: 64
Study 19636660 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (5 mg)
Number of subjects: 10
Study 19636660 — intervention group
Group type: EXPERIMENTAL
Intervention: Neosaxitoxin (10 microg)
Number of subjects: 10
Study 19636660 — intervention group
Group type: EXPERIMENTAL
Intervention: Neosaxitoxin (10 microg) plus Bupivacaine (5 mg)
Number of subjects: 10
Study 19636660 — intervention group
Group type: EXPERIMENTAL
Intervention: Neosaxitoxin (10 microg) plus Epinephrine (1:100,000)
Number of subjects: 10
Study 17869295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3047
Study 17869295 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 3047
Study 17869295 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 3047
Study 17869295 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 3047
Study 15557853 — intervention group
Group type: EXPERIMENTAL
Intervention: 2x Galilean telescope
Number of subjects: 16
Study 15557853 — intervention group
Group type: COMPARATOR
Intervention: Simple monocular tube
Number of subjects: 16
Study 11595622 — intervention group
Group type: EXPERIMENTAL
Intervention: Endogenous estradiol (E2)
Number of subjects: 704
Study 11595622 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex hormone-binding globulin (SHBG)
Number of subjects: 704
Study 11595622 — intervention group
Group type: EXPERIMENTAL
Intervention: Endogenous estrone (E1)
Number of subjects: 704
Study 11595622 — intervention group
Group type: EXPERIMENTAL
Intervention: Endogenous testosterone (T)
Number of subjects: 704
Study 9216352 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined medical and cognitive-behavioral treatment
Number of subjects: 94
Study 9216352 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment only
Number of subjects: 94
Study 8439511 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 103
Study 8439511 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 3087657 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate
Number of subjects: 45
Study 3087657 — intervention group
Group type: EXPERIMENTAL
Intervention: Astemizole
Number of subjects: 45
Study 3087657 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone dipropionate and Astemizole
Number of subjects: 45
Study 31528769 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone acetonide (TA) injection
Number of subjects: 51
Study 31528769 — intervention group
Group type: COMPARATOR
Intervention: Incision and curettage (I&C)
Number of subjects: 51
Study 29040223 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (100 mg·d)
Number of subjects: 28
Study 29040223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 26869286 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV)
Number of subjects: 20
Study 26869286 — intervention group
Group type: EXPERIMENTAL
Intervention: Local muscle vibration (LMV)
Number of subjects: 20
Study 26869286 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study 25445081 — intervention group
Group type: EXPERIMENTAL
Intervention: Social Effectiveness Therapy (SET)
Number of subjects: 106
Study 25445081 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure therapy alone
Number of subjects: 106
Study 25445081 — intervention group
Group type: COMPARATOR
Intervention: Wait list control
Number of subjects: 106
Study 22704056 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO-SELF Pain Control Program
Number of subjects: 179
Study 22704056 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 179
Study 20666949 — intervention group
Group type: EXPERIMENTAL
Intervention: Ablative curettage using a Thabet double‐bladed sharp curette
Number of subjects: 100
Study 20666949 — intervention group
Group type: COMPARATOR
Intervention: Overcurettage using Sims sharp curette
Number of subjects: 100
Study 20666949 — intervention group
Group type: EXPERIMENTAL
Intervention: Ablative curettage
Number of subjects: 100
Study 20666949 — intervention group
Group type: COMPARATOR
Intervention: Overcurettage
Number of subjects: 100
Study 20666949 — intervention group
Group type: COMPARATOR
Intervention: Hysterectomy specimens
Number of subjects: 100
Study 17872493 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab 250 mg
Number of subjects: 362
Study 17872493 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepolizumab 750 mg
Number of subjects: 362
Study 17872493 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 362
Study 16547376 — intervention group
Group type: EXPERIMENTAL
Intervention: Newborns of diabetic mothers (IDM)
Number of subjects: 53
Study 16547376 — intervention group
Group type: COMPARATOR
Intervention: Healthy newborns delivered at term (Control)
Number of subjects: 53
Study 11835697 — intervention group
Group type: EXPERIMENTAL
Intervention: Eucor (generic simvastatin)
Number of subjects: 43
Study 11835697 — intervention group
Group type: COMPARATOR
Intervention: Zocor (original simvastatin)
Number of subjects: 43
Study 11835697 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Eucor and Zocor
Number of subjects: 43
Study 10201670 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubating Laryngeal Mask (ILM)
Number of subjects: 20
Study 10201670 — intervention group
Group type: COMPARATOR
Intervention: Standard Laryngeal Mask Airway (LMA)
Number of subjects: 20
Study 7760780 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposed group (residents near the plant)
Number of subjects: 197
Study 7760780 — intervention group
Group type: COMPARATOR
Intervention: Unexposed group (referents)
Number of subjects: 197
Study 1706804 — intervention group
Group type: EXPERIMENTAL
Intervention: Apresoline
Number of subjects: 16
Study 1706804 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-release hydralazine (SRH)
Number of subjects: 16
Study 555600 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirbuterol 15 mg
Number of subjects: 24
Study 555600 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaproterenol 20 mg
Number of subjects: 24
Study 555600 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirbuterol 10 mg
Number of subjects: 24
Study 555600 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31466764 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-heat acclimation (HA)
Number of subjects: 13
Study 28216365 — intervention group
Group type: EXPERIMENTAL
Intervention: LiquoGuard automated device
Number of subjects: 152
Study 28216365 — intervention group
Group type: COMPARATOR
Intervention: Traditional dripping chamber-based system
Number of subjects: 152
Study 25914334 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigonella foenum‐graecum seed extract (libifem) at a dose of 600 mg/day
Number of subjects: 80
Study 25914334 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 24096616 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine/losartan 5/50 mg or 5/100 mg
Number of subjects: 99
Study 21872978 — intervention group
Group type: EXPERIMENTAL
Intervention: Coiled-end swan neck catheter (n = 40)
Number of subjects: 80
Study 21872978 — intervention group
Group type: COMPARATOR
Intervention: Straight-end swan neck catheter (n = 40)
Number of subjects: 80
Study 21872978 — intervention group
Group type: EXPERIMENTAL
Intervention: Coiled catheters (meta-analysis)
Number of subjects: 80
Study 19723320 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (intervention) for 48 hours
Number of subjects: 220
Study 19723320 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control) for 48 hours
Number of subjects: 220
Study 19723320 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine and Placebo (both groups)
Number of subjects: 220
Study 16707943 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal digital assistants (PDAs)
Number of subjects: 36
Study 16707943 — intervention group
Group type: COMPARATOR
Intervention: Paper resources (Control)
Number of subjects: 36
Study 15701215 — intervention group
Group type: EXPERIMENTAL
Intervention: Eszopiclone 3 mg
Number of subjects: 308
Study 15701215 — intervention group
Group type: EXPERIMENTAL
Intervention: Eszopiclone 2 mg
Number of subjects: 308
Study 15701215 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 308
Study 11343482 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal contraceptive patch
Number of subjects: 1417
Study 11343482 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive (OC)
Number of subjects: 1417
Study 9390667 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (ACZ) - 3 oral doses (14, 8, and 2 hours prior to testing)
Number of subjects: 0
Study 9390667 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 7942524 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg/day
Number of subjects: 8245
Study 7942524 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 40 mg/day
Number of subjects: 8245
Study 7942524 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 20 mg twice daily
Number of subjects: 8245
Study 7942524 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin 40 mg twice daily
Number of subjects: 8245
Study 7942524 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (various dosages)
Number of subjects: 8245
Study 7942524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8245
Study 3392125 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephradine
Number of subjects: 60
Study 3392125 — intervention group
Group type: COMPARATOR
Intervention: Flucloxacillin
Number of subjects: 60
Study 29995739 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video on aneuploidy testing
Number of subjects: 92
Study 29995739 — intervention group
Group type: COMPARATOR
Intervention: Control group (no video)
Number of subjects: 92
Study 26387039 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefitinib monotherapy (250 mg/body) for 8 weeks followed by cisplatin and docetaxel (40 mg/m2) on days 1, 8, 29, and 36, and concurrent 3‐dimensional conformal thoracic radiotherapy (2 Gy daily for 5 days a week to a total of 60 Gy)
Number of subjects: 21
Study 26387039 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin and docetaxel (40 mg/m2) on days 1, 8, 29, and 36, and concurrent 3‐dimensional conformal thoracic radiotherapy (2 Gy daily for 5 days a week to a total of 60 Gy)
Number of subjects: 21
Study 25311217 — intervention group
Group type: EXPERIMENTAL
Intervention: LHRHa plus AA
Number of subjects: 58
Study 25311217 — intervention group
Group type: COMPARATOR
Intervention: LHRHa alone
Number of subjects: 58
Study 23193534 — intervention group
Group type: EXPERIMENTAL
Intervention: BNO 1016
Number of subjects: 0
Study 23193534 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19574099 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n=17)
Number of subjects: 38
Study 19574099 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=21)
Number of subjects: 38
Study 18539624 — intervention group
Group type: EXPERIMENTAL
Intervention: Blastocyst biopsy followed by preimplantation genetic screening (PGS) for aneuploidy using 5-colour FISH
Number of subjects: 0
Study 15317320 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzylpenicilloyl-polylysine (5 mg/mL)
Number of subjects: 11
Study 15317320 — intervention group
Group type: COMPARATOR
Intervention: PrePen (5 mg/mL)
Number of subjects: 11
Study 15317320 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzylpenicilloyl-polylysine
Number of subjects: 11
Study 15317320 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme-linked immunosorbent assay (ELISA) for PrePen and benzylpenicilloyl-polylysine
Number of subjects: 11
Study 15317320 — intervention group
Group type: EXPERIMENTAL
Intervention: Cutaneous testing on penicillin-allergic individuals
Number of subjects: 11
Study 11583635 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmyocardial revascularization
Number of subjects: 197
Study 11583635 — intervention group
Group type: COMPARATOR
Intervention: Continued medical therapy
Number of subjects: 197
Study 9013058 — intervention group
Group type: EXPERIMENTAL
Intervention: four-pellet group (174 mg NET)
Number of subjects: 19
Study 9013058 — intervention group
Group type: EXPERIMENTAL
Intervention: five-pellet group (266.5 mg NET)
Number of subjects: 19
Study 9013058 — intervention group
Group type: EXPERIMENTAL
Intervention: four-pellet group
Number of subjects: 19
Study 9013058 — intervention group
Group type: EXPERIMENTAL
Intervention: five-pellet group
Number of subjects: 19
Study 9013058 — intervention group
Group type: EXPERIMENTAL
Intervention: four-pellet group and five-pellet group
Number of subjects: 19
Study 7875749 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (preoperative administration)
Number of subjects: 0
Study 7875749 — intervention group
Group type: COMPARATOR
Intervention: Narcotic premedication (control group)
Number of subjects: 0
Study 7875749 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (postoperative administration)
Number of subjects: 0
Study 3220958 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic 'imaginative involvement'
Number of subjects: 2
Study 3220958 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral distraction
Number of subjects: 2
Study 3220958 — intervention group
Group type: COMPARATOR
Intervention: Standard medical practice (Control)
Number of subjects: 2
Study 3220958 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups (Hypnotic, Distraction, Control)
Number of subjects: 2
Study 29257939 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative writing instruction combined with reminiscence group intervention over 10 weeks, 1-hour sessions, with various reminiscence themes and writing practices.
Number of subjects: 34
Study 27494933 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 cm head elevation
Number of subjects: 80
Study 27494933 — intervention group
Group type: COMPARATOR
Intervention: 6 cm head elevation
Number of subjects: 80
Study 26524285 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 45
Study 26524285 — intervention group
Group type: COMPARATOR
Intervention: Present Centered Therapy (PCT)
Number of subjects: 45
Study 21938543 — intervention group
Group type: EXPERIMENTAL
Intervention: Salsalate (3 g/day)
Number of subjects: 60
Study 21938543 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 21938543 — intervention group
Group type: EXPERIMENTAL
Intervention: HOMA‐IR
Number of subjects: 60
Study 20494369 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic treatment
Number of subjects: 203
Study 20494369 — intervention group
Group type: COMPARATOR
Intervention: Surveillance (Control)
Number of subjects: 203
Study 20494369 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis
Number of subjects: 203
Study 20494369 — intervention group
Group type: EXPERIMENTAL
Intervention: Febrile urinary tract infections
Number of subjects: 203
Study 18301136 — intervention group
Group type: EXPERIMENTAL
Intervention: Early aggressive approach (coronary angiography within 48 hours of admission and, when indicated, coronary revascularization)
Number of subjects: 700
Study 18301136 — intervention group
Group type: COMPARATOR
Intervention: Initially conservative approach (optimal medical therapy with coronary angiography in selected cases with refractory ischemia)
Number of subjects: 700
Study 17133931 — intervention group
Group type: EXPERIMENTAL
Intervention: New fluoride varnish (white varnish)
Number of subjects: 60
Study 17133931 — intervention group
Group type: COMPARATOR
Intervention: Control fluoride varnish (brown varnish)
Number of subjects: 60
Study 14606740 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS 1 (4 Hz, 200 micros)
Number of subjects: 15
Study 14606740 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS 2 (110 Hz, 200 micros)
Number of subjects: 15
Study 14606740 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 15
Study 10731276 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 doses of beta-radiation (28, 35, and 42 Gy)
Number of subjects: 26
Study 10731276 — intervention group
Group type: COMPARATOR
Intervention: Placebo (dummy wire)
Number of subjects: 26
Study 9365354 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic training program (6 weeks, 3 days/week, 40 minutes/day)
Number of subjects: 15
Study 1585349 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative radiation therapy combined with hyperthermia
Number of subjects: 69
Study 1585349 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative radiation therapy without hyperthermia (control group)
Number of subjects: 69
Study 2986474 — intervention group
Group type: EXPERIMENTAL
Intervention: magnesium trisilicate mixture (BP) 30 ml
Number of subjects: 80
Study 2986474 — intervention group
Group type: EXPERIMENTAL
Intervention: metoclopramide 10 mg intramuscularly
Number of subjects: 80
Study 2986474 — intervention group
Group type: EXPERIMENTAL
Intervention: ranitidine 150 mg orally on the night prior to, and the morning of, surgery
Number of subjects: 80
Study 2986474 — intervention group
Group type: EXPERIMENTAL
Intervention: metoclopramide 10 mg intramuscularly in combination with oral ranitidine 150 mg
Number of subjects: 80
Study 2986474 — intervention group
Group type: COMPARATOR
Intervention: no medication
Number of subjects: 80
Study 30727947 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy (OT) with 8 extra home sessions over 4 supplementary months
Number of subjects: 240
Study 30727947 — intervention group
Group type: COMPARATOR
Intervention: Routine OT delivered as recommended (12 to 15 initial sessions of OT over 3/4 months)
Number of subjects: 240
Study 29579601 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-6 (IL-6)
Number of subjects: 668
Study 29579601 — intervention group
Group type: EXPERIMENTAL
Intervention: LpPLA2 mass/activity
Number of subjects: 668
Study 29579601 — intervention group
Group type: EXPERIMENTAL
Intervention: high-sensitivity C-reactive protein (hsCRP)
Number of subjects: 668
Study 27997007 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0
Study 27997007 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 0
Study 25257450 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin-block group
Number of subjects: 60